Risk factor
Very poor trading liquidity
Profitability factor
Very strong margins and returns
About
Biohit Oyj, a biotechnology company, produces diagnostic tests and analysis systems for use in research institutions and healthcare industries worldwide. The company's diagnostic tests product range includes the GastroPanel test for diagnosing diseases of the stomach and associated risks; Biohit Active B12, a test for measuring the levels of active vitamin B12; Biohit Total, an...
Company Valuation
From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, 'expens
Target Price
The average target price of BIOBV.HE is 3.7 and suggests 14% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendati
Buy
Sell